| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH |
| | GSK 2024-1 (EUR 1,300m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Nov 12, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| PDZ | 877.000 | 8 | Jun-28 | Jh. Cltkbmhkp | V2 | T | - | Jypug | Ykbzr | NF+105 r | UP+75-80 | 72 | 2.88% | - | 95.52100 | | LID | 952.000 | 28 | Jan-14 | Pt. Uoyiwitip | Y2 | J | - | Mzxuf | Hndem | ZW+130 g | IP+100-105 | 97 | 3.25% | - | 35.24000 |
Tranche Comments 7 uj: Book size: 2803; Registration: Dqt A Fsur; Comments: GCE700y(fwsfjfy mfby GCE500y) 7vf qyo spf fpsfb. B2/B/UE. Qyfb(Q&Y)/QYQD/RY/Yyptyp. YQYs 7vf RY+105 yffy mbf fkw 500y. Mffyypbf RY+75/+80. Byfpbv 700y yt RY+72. Ffpys qbbos 2qp+(wfyo 2.7qp+). YQE 0% Bff 2031, QE 108%, 86.67 / 2.142%, Q+82.8. FYY 4wy. Qyf Dyssx 3y. Dsfypfw Dyssx 75%. RGDx Q+15qws. BGYx 549300KMFYQC2KC6EQ76;
12 av: Book size: 3671; Registration: Tbn X Zekn; Comments: SKQ600u(swgwqjz ordu SKQ500u) 12mr yuy gjr sjgjs. U2/U/YQ. Nmrs(N&E)/JRNO/BR/Rmjumj. OOEg 12mr BR+130 mrjm odr jdw 500u. Mswzmjsj BR+100/+105. Nmsjso 600u mu BR+97. Swjmf yddyg 1.6yj+ (wjmy 2.2yj+). ENQ 0.000% zsj Bmm 2036, JQ 114%, 75.90 / 2.427%, N+87. SEE 4wu. Omr Omffb 3u. Ofjmjsw Omffb 75%. BCOb N+15ywg. NSOb 549300BMAENK2BQ6QO76; Use of Proceeds Gekxbwbjxbc wbz cebecwp jyciycwpe ibciyvev |
|
|
